San Francisco, 27
February, U.S. Depyrogenated Sterile Empty Vials Market Size, Share &
Trends Analysis Report By Product (2 ml, 5 ml, 10 ml, 20 ml), By End Use
(Clinical Labs, Componding Pharmacies), And Segment Forecasts, 2018 – 2025.
The U.S.depyrogenated sterile empty vials market size is likely to
reach USD 3.5 billion by 2025, according to a new report by Grand View
Research, Inc., progressing at a CAGR of 5.2% during the forecast period.
Technological advancements in pharmaceutical packaging process, growing funding
by government organizations, and flourishing biologics market in the U.S. are
some of the key trends escalating market growth. Stringent regulations laid by
the government for parenteral are also poised to augment the market.
Rising number of clinical labs
in the country is resulting in an increased number of medical and diagnostic
tests. This, in turn, is fueling the demand for depyrogenated sterile empty
vials. Increasing number of compounding laboratories and research institutes in
the U.S. is boosting the demand for these vials in the market. Moreover,
continual growth in the pharmaceutical and biotechnology industry is further
projected to drive the market.
Increasing number of
collaborations in order to achieve innovative packaging technology is also
providing an upthrust to the market. Rising incidence of infectious &
non-infectious diseases and growing number of clinical studies are translating
into a greater demand for these vials. Besides this, the government is backing
the promotion of pharmaceutical, medical, and biotechnological researches,
which is anticipated to work in favor of the market.
Access Full Research
Report On U.S. Depyrogenated Sterile Empty Vials Market Analysis:
Further key findings from the report suggest:
·
More than 20 ml depyrogenated
sterile empty vials emerged as the largest segment in terms of revenue in 2017
owing to rising incidence of infectious & non-infectious diseases and
increasing investments in the biopharmaceutical sector
·
Others, which include
pharmaceutical manufacturers and academic & research institutes, formed the
most prominent end-use segment in 2017. The growth of the segment can be
attributed to expanding base of medical & biotech research institutes and
upswing in pharmaceutical manufacturing
·
Thermo Fisher Scientific, Inc.;
Gerresheimer AG; SCHOTT AG; and DWK Life Sciences are the major players
operating in the market. This market is considerably fragmented and market
entry barrier is high.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the U.S.
depyrogenated sterile empty vials market on the basis of product and end-use:
Depyrogenated Sterile Empty
Vials Product Outlook (Revenue, USD Million, 2014 - 2025)
·
2 ml
·
5 ml
·
10 ml
·
20 ml
·
More than 20 ml
Depyrogenated Sterile Empty
Vials End-use Outlook (Revenue, USD Million, 2014 - 2025)
·
Clinical Labs
·
Compounding Labs
·
Others
Browse Press
Release of this Report:
www.grandviewresearch.com/press-release/us-depyrogenated-sterile-empty-vials-market-analysis
www.grandviewresearch.com/press-release/us-depyrogenated-sterile-empty-vials-market-analysis
About Grand View
Research
Grand View
Research provides syndicated as well as customized research reports and
consulting services on 46 industries across 25 major countries worldwide. This
U.S.-based market research and consulting company is registered in California
and headquartered in San Francisco. Comprising over 425 analysts and
consultants, the company adds 1200+ market research reports to its extensive
database each year. Supported by an interactive market intelligence platform,
the team at Grand View Research guides Fortune 500 companies and prominent
academic institutes in comprehending the global and regional business
environment and carefully identifying future opportunities.
For more
information: www.grandviewresearch.com/
No comments:
Post a Comment